Coronary heart disease in HIV-infected patients
- 1 June 2005
- journal article
- review article
- Published by Springer Nature in Current HIV/AIDS Reports
- Vol. 2 (2) , 68-73
Abstract
Increased risk of coronary heart disease has emerged as a long-term concern among HIV-infected patients receiving antiretroviral therapy. HIV-infected patients may have modifiable risk factors for heart disease that are associated with HIV itself, antiretroviral therapy, or factors unrelated to HIV. Dyslipidemia, insulin resistance, and diabetes mellitus are often multifactorial in origin. Patients with lipodystrophy frequently have a constellation of metabolic changes that may predispose them to accelerated atherosclerosis. There is also concern about contributions of chronic inflammation and prothrombotic tendencies in the pathogenesis of coronary heart disease in the HIV-infected population. Several epidemiological studies support an increased relative risk of myocardial infarction in HIV-infected patients on highly active antiretroviral therapy. Although absolute risk appears low in the short term, patients may accrue significant risk over time. Clinicians are advised to assess coronary heart disease risk in HIV-infected patients and to intervene to reduce the impact of modifiable risk factors.Keywords
This publication has 39 references indexed in Scilit:
- Nevirapine and Efavirenz Elicit Different Changes in Lipid Profiles in Antiretroviral- Therapy-Naive Patients Infected with HIV-1PLOS Medicine, 2004
- Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive PatientsA 3-Year Randomized TrialJAMA, 2004
- Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection†Hepatology, 2004
- Clinical Features of Acute Coronary Syndromes in Patients With Human Immunodeficiency Virus InfectionCirculation, 2004
- Prevalence of Hypertension in HIV-Positive Patients on Highly Active Retroviral Therapy (HAART) Compared with HAART-Na ve and HIV-Negative Controls: Results from a Norwegian Study of 721 PatientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2003
- Elevated Blood Pressure in HIV-Infected Individuals Receiving Highly Active Antiretroviral TherapyHIV Research & Clinical Practice, 2003
- Hypertension among HIV patientsJournal Of Hypertension, 2003
- A Randomized Trial of Simplified Maintenance Therapy with Abacavir, Lamivudine, and Zidovudine in Human Immunodeficiency Virus InfectionThe Journal of Infectious Diseases, 2002
- Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and LipodystrophyClinical Infectious Diseases, 2001
- The Mechanism of Insulin Resistance Caused by HIV Protease Inhibitor TherapyJournal of Biological Chemistry, 2000